US stock · US markets · public data

VRTX

Vertex Pharmaceuticals Inc · Healthcare

Reference price$499.61Updated according to the public source
P/E28.93
P/B6.25
ROE23.54%
DY 12M0.00%
Net margin—
Net debt/equity—
Market capUS$ 126.6 B
Volume (shares)1,123,175
SectorHealthcare
Overview

About VRTX

Demonstrações públicas consolidadas + SEC Company Facts

Vertex Pharmaceuticals Inc (VRTX) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data

The source returned no recent distributions for this asset.

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$9,869,200,000.00$11,020,100,000.00$12,001,300,000.00—
Operating Income$3,832,000,000.00-$232,900,000.00$4,173,300,000.00—
Net Income$3,619,600,000.00-$535,600,000.00$3,953,200,000.00—
EPS Diluted$13.89 / share-$2.08 / share$15.32 / share—

Balance sheet

Account2023202420252026
Total Assets$22,730,200,000.00$22,533,200,000.00$25,643,000,000.00—
Total Liabilities$5,149,800,000.00$6,123,600,000.00$6,977,200,000.00—
Total Equity$17,580,400,000.00$16,409,600,000.00$18,665,800,000.00—
Shares Outstanding257,091,441 shares258,307,816 shares256,789,869 shares254,034,190 shares
Cash & Investments$13,716,100,000.00$11,223,800,000.00$12,320,400,000.00—

Cash flow

Account2023202420252026
Operating Cash Flow$3,537,300,000.00-$492,600,000.00$3,631,400,000.00—
Capital Expenditures$200,400,000.00$297,700,000.00$437,600,000.00—
Free Cash Flow$3,336,900,000.00-$790,300,000.00$3,193,800,000.00—
FAQ

Frequently asked questions

What is the price of VRTX?

The reference price available for VRTX is $499.61.

What is the P/E of VRTX?

The P/E ratio of VRTX is 28.93. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of VRTX?

The P/B of VRTX is 6.25. This compares price with reported book value per share.

What is the ROE of VRTX?

The ROE (Return on Equity) of VRTX is 23.54%. This relates the reported net result to shareholders' equity.

What is the dividend yield of VRTX?

The dividend yield of VRTX is 0.00%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of VRTX?

The market capitalization of VRTX is US$ 126.6 B.

What sector is VRTX in?

VRTX operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.